Trial Profile
Predictive factors for survival of hepatocellular carcinoma patients treated with sorafenib by correlating the imaging findings and survival.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 14 Dec 2015 New trial record